Bio-printing in the context of end-to-end scalable tissue-engineered ATMP manufacturing
3D bio-printing technologies have been constantly evolving over the past 15 years in order to address health challenges, such as the need for regeneration or replacement of human organs and tissues. To date, there are no bio-printed tissue engineered products in the EU market and no active clinical trials...
Institutions
- KU Leuven (BE)
Publication Details
- Journal
- Cell and Gene Therapy Insights
- Published
- 2024-12-12
- DOI
- https://doi.org/10.18609/cgti.2024.182
- Primary Topic
- 3D Printing in Biomedical Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00